Oncomine Myeloproliferative Neoplasm (MPN) Panel in UAE – 4600 AED – DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee

99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing

Premium Logistics

Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Transport & VIP Mobile Phlebotomy

Clinical Guidance

Telephonic Post-Test Clinical Guidance for Result Interpretation by a Molecular Pathologist

Insurance

Direct Billing Verification via WhatsApp: +971 54 548 8731

Test Overview & Methodology

The Oncomine MPN Panel is a Next‑Generation Sequencing (NGS) test that analyzes key genes (JAK2, CALR, MPL, and others) associated with myeloproliferative neoplasms, aiding accurate diagnosis, prognosis, and targeted therapy selection. This advanced genomic profiling surpasses single‑gene testing, delivering comprehensive mutation detection from blood or bone marrow samples.

Feature	Our Test (Oncomine MPN Panel)	Closest Alternative (Single‑Gene PCR)
Method	NGS – Multi‑gene profiling (≥ 40 genes)	Single‑gene Polymerase Chain Reaction
Gene Coverage	JAK2, CALR, MPL, ASXL1, EZH2, SRSF2 and more	One mutation at a time
Turnaround Time	Reports 15th / 30th of the same month	Variable; often 7–14 days per gene
Sample	Whole blood or bone marrow (EDTA, refrigerated)	Blood only; may require multiple draws
Price	4600 AED	Often 1200–1800 AED per gene

Physician Insight & Safety Protocols

“As a clinical pathologist with DHA credentials, I understand that receiving a genetic diagnosis can be emotionally taxing. This panel offers robust molecular insights, but results must be interpreted in the context of your full clinical picture and blood counts. Rest assured, our team provides compassionate guidance to ensure you are never alone in this journey.”

— Mr. Prabhakar Reddy Kalathoor | Specialist Diagnostic Radiology | DHA: 61713011

Advisory & Medication Safety

Important Medication Advisory

⚠️ Do not discontinue any prescribed medication without consulting your doctor. This test provides genetic information but does not replace ongoing clinical management.

Exclusion Criteria & Emergency Red Flags

Exclusion: Recent allogeneic bone marrow transplant (within 1 month) – donor DNA may interfere with results.
Exclusion: Severe thrombocytopenia (platelets <20,000/µL) – bone marrow aspiration requires physician clearance.
Emergency Red Flags: If you experience sudden bleeding, severe bone pain, chest pain, shortness of breath, or leg swelling before collection, seek immediate emergency care; do not wait for the scheduled draw.

Patient FAQ & Clinical Guidance

1. What genes are included in the Oncomine MPN Panel?

The panel targets driver mutations in JAK2 V617F, CALR, and MPL, plus prognostic genes like ASXL1, EZH2, and SRSF2, delivering a complete molecular profile for accurate MPN subtyping.

2. How is the sample collected, and is home collection available?

Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. A trained phlebotomist will collect either peripheral whole blood or bone marrow under sterile conditions, ensuring refrigerated transport to our ISO‑certified lab.

3. How soon will I receive my results, and who interprets them?

Reports are released by the 15th or 30th of the month, with telephonic interpretation by our specialist hematopathologist to guide your next clinical steps.

UAE Regulatory & Data Privacy Adherence

Data Privacy & Legal Compliance

Your health data is protected under Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing and patient consent are performed in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.

Clinical & Logistical Metadata

Test Name	Oncomine Myeloproliferative Neoplasm (MPN) Panel
Price (AED)	4,600
Turnaround Time	Reports released by the 15th and 30th of each month
Sample Type / Matrix	Peripheral whole blood or bone marrow (EDTA, refrigerated). Collection: Hospital-only procedure.
Methodology Used	Next‑Generation Sequencing (NGS) – Multi‑gene panel (≥40 genes)
ICD-10-CM Code	D47.1 (Chronic myeloproliferative disease)
LOINC Code	92197-1 (Myeloproliferative neoplasm gene panel in Blood or Tissue by Sequencing)
DHA Facility License & Laboratory Address	License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE